Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  American Journal of Cardiology

• Publication date

  2004-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AMJCARD.2004.05.026PMID 15342293
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

  2002cited by this paper
• For personal use. Only reproduce with permission from The Lancet Publishing Group. Late cardiopulmonary complication of ventriculo-atrial shunt

  2001cited by this paper
• Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

  2001cited by this paper
• Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.

  2001cited by this paper

• Effect of P2Y12 Inhibitors on Major Adverse Cardiovascular Events After Coronary Artery Bypass Graft Surgery: A Population‐Based Cohort Study

  2025cites this paper
• The relationship between dual antiplatelet treatment (DAPT) score and saphenous venous grafts patency after coronary artery bypass grafting surgery

  2021cites this paper
• Efficacy and Safety of Dual Antiplatelet Therapy on Graft Patency After Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial

  2020cites this paper
• Early dual antiplatelet therapy versus aspirin monotherapy after coronary artery bypass surgery: survival and safety outcomes.

  2020cites this paper
• Meta-Analysis of Aspirin Versus Dual Antiplatelet Therapy Following Coronary Artery Bypass Grafting.

  2018cites this paper
• the ART (Arterial Revascularization Trial) Investigators (2017). Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1-year outcomes in the Arterial Revascularization Trial. European Journal of Cardio-Thoracic (3),

  2018cites this paper
• Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).

  2018cites this paper
• Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events.

  2017cites this paper
• Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1‐year outcomes in the Arterial Revascularization Trial†

  2017cites this paper
• Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.

  2017cites this paper
• ASpirin and Plavix Following Coronary Artery Bypass Grafting ( ASAP - CABG ): A Randomized, Double - Blind, Placebo - Controlled Pilot Trial

  2016cites this paper
• Benefit and safety of dual antiplatelet therapy after coronary artery bypass grafting for off-pump CABG: a systematic review and meta-analysis.

  2015cites this paper
• Dual antiplatelet therapy use by Canadian cardiac surgeons.

  2015cites this paper
• Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting in the Setting of Acute Coronary Syndrome.

  2015cites this paper
• Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials

  2015influential citation
• The effectiveness, side effects and acceptability of locally available brand of Clopidogrel (Osvix) as antiplatelet tablet in CABG patients

  2014cites this paper
• Effect of clopidogrel use post coronary artery bypass surgery on graft patency.

  2014cites this paper
• Benefits and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies.

  2012cites this paper
• Clopidogrel compared with other antiplatelet agents for secondary prevention of vascular events in adults undergoing percutaneous coronary intervention: clinical and cost-effectiveness analyses.

  2012cites this paper
• Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cites this paper
• Treatment strategies for women with coronary artery disease

  2012cites this paper
• Clopidogrel

  2012cites this paper
• Use of Aspirin and Clopidogrel After Coronary Artery Bypass Graft Surgery

  2012cites this paper
• Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

  2012cites this paper
• Drug Class Review: Newer Antiplatelet Agents: Final Update 2 Report

  2011cites this paper
• Efficacy of post-operative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction.

  2011cites this paper
• Secondary Stroke Prevention in Women

  2011cites this paper
• Hypercoagulable state after off-pump coronary artery bypass grafting: evidence, mechanisms and implications

  2011cites this paper
• Use of clopidogrel post-coronary artery bypass surgery in canadian patients with acute coronary syndromes.

  2011cites this paper
• Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.

  2011cites this paper
• Clinical Research Use of Clopidogrel Post-Coronary Artery Bypass Surgery in Canadian Patients With Acute Coronary Syndromes

  2011cites this paper
• Impact of clopidogrel use on mortality and major bleeding in patients undergoing coronary artery bypass surgery.

  2010cites this paper
• Clopidogrel versus Other Antiplatelet Agents in the Secondary Prevention of Vascular Events in Adults with Cerebrovascular Disease: Clinical and Cost-Effectiveness Analyses.

  2010cites this paper
• Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy

  2009cites this paper
• Evidence for using clopidogrel alone or in addition to aspirin in post coronary artery bypass surgery patients.

  2009cites this paper
• Антиагрегантная терапия у больных ишемической болезнью сердца после хирургической реваскуляризации миокарда

  2009cites this paper
• Guideline on antiplatelet and anticoagulation management in cardiac surgery.

  2008cites this paper
• Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.

  2007cites this paper
• Blutungen nach herzchirurgischen Operationen

  2006cites this paper
• Should high risk patients receive clopidogrel as well as aspirin post coronary arterial bypass grafting?

  2006cites this paper
• Does clopidogrel improve the long-term outcome after coronary artery bypass surgery?

  2005influential citation
• HANNA PUHAKKA Gene Therapy for Vascular Thickening

  2005cites this paper
• Aspirin and Clopidogrel Taken Until 2 Days Prior to Coronary Artery Bypass Graft Surgery Is Associated with Increased Postoperative Drainage Loss

  2005cites this paper
• Peri-procedural myocardial injury: 2005 update.

  2005cites this paper
• The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]

  2005cites this paper